794

GLUTEN DEPENDENT ACTIVATION OF CD4+ T CELLS BY MHC CLASS II EXPRESSING INTESTINAL EPITHELIAL CELLS

Date
May 20, 2024

BACKGROUND AND AIM: Intestinal epithelial cells (IECs) are emerging as potential regulators of CD4+ T cell responses through MHC class II expression. However, their role as antigen-presenting cells and in the activation of gluten-reactive CD4+ T cells has never been proven.

METHODS: We assessed MHC Class II expression in IECs using biopsies from active and treated CeD patients, as well as in gluten-immunized and non-immunized DR3-DQ2.5 transgenic mice that lack murine MHC Class II. Organoid monolayers were developed from DR3-DQ2.5 mice, treated with or without IFN-γ, and epithelial MHC Class II expression was measured by flow cytometry. We studied the functional consequences of MHC Class II expression on organoid monolayers by co-culturing monolayers from DR3.DQ2.5 mice with splenic human (h)CD4+ T cells isolated from gluten-immunized double transgenic DR3-DQ2.5-hCD4 mice. Co-cultures were treated with zein (a non-gluten protein), gluten, gluten pre-digested with elastase-producing Pseudomonas aeruginosa PA14, or gluten pre-digested with its lasB mutant. Following 4-days of co-culture, T-cell proliferation, activation, and cytokine release were assessed.

RESULTS: MHC Class II expression was higher in IEC from both active CeD patients and gluten-immunized DR3-DQ2.5 mice than in controls. Organoid monolayers from gluten-immunized mice demonstrated MHC Class II expression, which increased following IFN-γ treatment. Gluten, but not zein, treatment of organoid monolayers cultured with CD4+ T cells increased T cell proliferation, expression of activation markers (CD25, CD44, and CD69), and production of proinflammatory cytokines IL-2, IFN-γ, and IL-15. Organoid monolayers exposed to gluten pre-digested by elastase-producing P. aeruginosa PA14 showed increased CD4+ T cell proliferation, activation, and cytokine production compared with monolayers exposed to gluten or gluten pre-digested with the lasB mutant.

CONCLUSIONS: Under inflammatory conditions, IECs upregulate MHC Class II, have the capacity to present gluten antigen, and activate gluten-specific CD4+ T cells, which is further potentiated by microbial elastase digestion of gluten. IECs may serve to further increase injury to the epithelium caused by gluten-specific CD4+ T cells in CeD.

Tracks

Related Products

Thumbnail for MICROBIOTA FROM PATIENTS WITH CROHN’S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE
MICROBIOTA FROM PATIENTS WITH CROHN’S DISEASE INDUCES BEHAVIOURAL CHANGES IN MICROBIOTA-HUMANIZED MICE
BACKGROUND AND AIMS: Peptostreptococcus stomatis (_P. stomatis_) is an enriched bacterium in colorectal cancer (CRC) patients as compared to healthy subjects in multiple cohorts. However, the potential role of _P. stomatis_ in colorectal tumorigenesis remains obscure…
Thumbnail for Gut Instincts: Exploring the Interplay of the Microbiome and Gut-Brain Axis
Gut Instincts: Exploring the Interplay of the Microbiome and Gut-Brain Axis
SOCIETY: AGA This session will delve into the cutting edge research on the bidirectional communication between the gut and the brain, and delineating the role of microbial communities in dysregulation of the gut brain axis…
Thumbnail for Advancing-microbially Based Therapies for Celiac Disease and Other Food Sensitivities
Advancing-microbially Based Therapies for Celiac Disease and Other Food Sensitivities
SOCIETY: AGA Genes and dietary gluten are necessary, but insufficient, to develop celiac disease, a common autoimmune enteropathy with systemic manifestations and co-morbid associations. Microbes, in the form of infections and perturbations of the gut microbiome, have emerged as key cofactors…
Thumbnail for INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY
INVESTIGATING MECHANISMS THAT DRIVE SYMPTOMS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND PERCEIVED GLUTEN SENSITIVITY
BACKGROUND: Irritable bowel syndrome (IBS) is a common disorder with complex pathophysiological mechanisms. Prior studies suggest that 25-50% of patients with diarrhea-predominant IBS (IBS-D) have evidence of bile acid (BA) diarrhea (BAD)…